(Q43769391)

English

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study (English)

1 reference

Europe PubMed Central

26 November 2017

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

based on heuristic

inferred from title

Michael Hudgens

2

object named as

Michael G Hudgens

1 reference

Europe PubMed Central

26 November 2017

5

object named as

Kari Syrjänen

1 reference

Europe PubMed Central

26 November 2017

author name string

Joseph Monsonego

1

1 reference

Europe PubMed Central

26 November 2017

Laurent Zerat

3

1 reference

Europe PubMed Central

26 November 2017

Jean-Claude Zerat

4

1 reference

Europe PubMed Central

26 November 2017

Philippe Halfon

6

1 reference

Europe PubMed Central

26 November 2017

Fabrice Ruiz

7

1 reference

Europe PubMed Central

26 November 2017

Jennifer S Smith

8

1 reference

Europe PubMed Central

26 November 2017

language of work or name

0 references

publication date

8 December 2010

1 reference

Europe PubMed Central

26 November 2017

International Journal of Cancer

1 reference

Europe PubMed Central

26 November 2017

129

1 reference

Europe PubMed Central

26 November 2017

3

1 reference

Europe PubMed Central

26 November 2017

691-701

1 reference

Europe PubMed Central

26 November 2017

Report on consensus conference on cervical cancer screening and management

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Reproducibility of classification and correction for verification bias as determinants of performance of Papanicolaou smear cytology in the screening setting: experience from the New Independent States of the former Soviet Union cohort study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Liquid-based cytology for primary cervical cancer screening: a multi-centre study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Papillomaviruses in the causation of human cancers - a brief historical account

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Human papillomavirus testing for cervical cancer screening: results from a 6-year prospective study in rural China

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Analytical characterization of the APTIMA HPV Assay

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Human papillomavirus genotype specificity of hybrid capture 2

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

International terminology of colposcopy: an updated report from the International Federation for Cervical Pathology and Colposcopy.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Assessment of diagnostic tests when disease verification is subject to selection bias

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Age-specific prevalence of infection with human papillomavirus in females: a global review

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Age distribution of human papillomavirus infection and cervical neoplasia reflects caveats of cervical screening policies.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Primary HPV screening for cervical cancer prevention: results from European trials

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Correcting for verification bias in studies of a diagnostic test's accuracy.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

A New Generation of Studies of Human Papillomavirus DNA Testing in Cervical Cancer Screening

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25726

21 January 2018

Identifiers

10.1002/IJC.25726

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43769391&oldid=2103173861"